Cleves Thomas A
Known title: SVP, Corporate AffairsCIK: 0001878690
Cleves Thomas A's purchase track record
Cleves Thomas A has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/9/2023 | SLVM | $251K | -11.7% | -17.2% | +13.6% |
| 11/15/2021 | SLVM | $627K | +17.3% | +47.1% | -14.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SLVM | ▲ Buy | Grant | 3,419 | $0 | 3/1/2024 | View on chart |
| SLVM | ▼ Sell | Tax Withholding | 2,651 | $160K | 3/1/2024 | View on chart |
| SLVM | ▲ Buy | Open Market | 4,976 | $251K | 3/9/2023 | View on chart |
| SLVM | ▼ Sell | Tax Withholding | 2,274 | $112K | 3/1/2023 | View on chart |
| SLVM | ▲ Buy | Grant | 3,668 | $0 | 3/1/2023 | View on chart |
| SLVM | ▼ Sell | Tax Withholding | 1,814 | $63K | 3/1/2022 | View on chart |
| SLVM | ▲ Buy | Grant | 5,199 | $0 | 2/21/2022 | View on chart |
| SLVM | ▲ Buy | Open Market | 19,340 | $627K | 11/15/2021 | View on chart |
| SLVM | ▲ Buy | Grant | 22,487 | $0 | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Sylvamo Price Targets Lowered by BofA and Truist
Bank of America and Truist Securities recently lowered their price targets for Sylvamo, citing updated outlooks. While BofA maintains a Neutral rating with a $42 target, Truist keeps a Buy rating but reduced its target to $40. These adjustments place the new targets below the current average analyst estimate of $50.40, reflecting a more cautious view on the company's near-term valuation.
Sylvamo Price Targets Lowered by BofA and Truist. Bank of America and Truist Securities recently lowered their price targets for Sylvamo, citing updated outlooks. While BofA maintains a Neutral rating with a $42 target, Truist keeps a Buy rating but reduced its target to $40. These adjustments place the new targets below the current average analyst estimate of $50.40, reflecting a more cautious view on the company's near-term valuation.